Mon, October 14, 2019

by: WOPRAI

Richard Sunderland Maintained (CMS) at Buy with Decreased Target to $71 on, Oct 14th, 2019

by: WOPRAI

Charles Peters Maintained (BRO) at Buy with Increased Target to $39 on, Oct 14th, 2019

by: WOPRAI

Michael Carrier Downgraded (BX) to Hold on, Oct 14th, 2019

by: WOPRAI

Jayson Bedford Maintained (BSX) at Strong Buy with Decreased Target to $48 on, Oct 14th, 2019

by: WOPRAI

Andrew Schmitt Maintained (WU) at Strong Sell with Increased Target to $21 on, Oct 14th, 2019

by: WOPRAI

Jay Sole Downgraded (TPR) to Hold and Held Target at $25 on, Oct 14th, 2019

by: WOPRAI

Christopher Turnure Maintained (SRE) at Hold with Increased Target to $74 on, Oct 14th, 2019

by: WOPRAI

Drew Babin Upgraded (UDR) to Buy on, Oct 14th, 2019

by: WOPRAI

Mitch Steves Maintained (ASML) at Buy with Increased Target to $270 on, Oct 14th, 2019

by: WOPRAI

Chris Shaw Upgraded (ASH) to Strong Buy and Held Target at $88 on, Oct 14th, 2019

by: WOPRAI

Philip Gibbs Maintained (ATI) at Buy with Decreased Target to $28 on, Oct 14th, 2019

by: WOPRAI

John Glass Maintained (WEN) at Hold with Increased Target to $22 on, Oct 14th, 2019

by: WOPRAI

Nick Setyan Maintained (WEN) at Hold with Increased Target to $22 on, Oct 14th, 2019

by: WOPRAI

Ananda Baruah Upgraded (WDC) to Strong Buy on, Oct 14th, 2019

by: WOPRAI

David Leiker Maintained (SNA) at Hold with Increased Target to $165 on, Oct 14th, 2019

by: WOPRAI

Michael Carrier Upgraded (VRTS) to Strong Buy on, Oct 14th, 2019

Fri, October 11, 2019

by: WOPRAI

Jamie Cook Maintained (CAT) at Buy with Decreased Target to $149 on, Oct 11th, 2019

by: WOPRAI

Andrew Obin Downgraded (AME) to Hold on, Oct 11th, 2019

by: WOPRAI

Matthew Harrison Maintained (BIIB) at Sell with Increased Target to $212 on, Oct 11th, 2019

by: WOPRAI

Matthew Harrison Maintained (BGNE) at Buy with Decreased Target to $200 on, Oct 11th, 2019

by: WOPRAI

Ross Smotrich Maintained (ARE) at Hold with Increased Target to $153 on, Oct 11th, 2019

by: WOPRAI

Krish Sankar Downgraded (AEIS) to Hold and Decreased Target to $57 on, Oct 11th, 2019

by: WOPRAI

Daniel Ives Maintained (AAPL) at Buy with Increased Target to $66 on, Oct 11th, 2019

by: WOPRAI

Ittai Kidron Maintained (TWLO) at Buy with Decreased Target to $145 on, Oct 11th, 2019

by: WOPRAI

Alex Zukin Initiated (TWLO) at Buy and Held Target at $135 on, Oct 11th, 2019

by: WOPRAI

Mark Mahaney Upgraded (TTD) to Buy and Held Target at $25 on, Oct 11th, 2019

by: WOPRAI

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $104 on, Oct 11th, 2019

by: WOPRAI

Selman Akyol Downgraded (TRGP) to Hold and Held Target at $41 on, Oct 11th, 2019

by: WOPRAI

Andrew Burns Initiated (VSTO) at Hold on, Oct 11th, 2019

by: WOPRAI

Alex Kramm Maintained (VIRT) at Strong Buy with Decreased Target to $21 on, Oct 11th, 2019

by: WOPRAI

Steven Duong Initiated (VLY) at Buy and Held Target at $13 on, Oct 11th, 2019

by: WOPRAI

Vikram Malhotra Downgraded (VNO) to Hold on, Oct 11th, 2019

Thu, October 10, 2019

by: WOPRAI

Vivek Juneja Maintained (BK) at Sell with Decreased Target to $45 on, Oct 10th, 2019

by: WOPRAI

Julien Dumoulin-Smith Upgraded (BKH) to Strong Buy on, Oct 10th, 2019

by: WOPRAI

Rajeev Lalwani Maintained (UAL) at Buy with Decreased Target to $103 on, Oct 10th, 2019

by: WOPRAI

Rajeev Lalwani Maintained (TXT) at Hold with Increased Target to $51 on, Oct 10th, 2019

by: WOPRAI

Brian Meredith Maintained (AFL) at Hold with Increased Target to $53 on, Oct 10th, 2019

by: WOPRAI

Toni Kaplan Maintained (ARMK) at Hold with Increased Target to $43 on, Oct 10th, 2019

by: WOPRAI

Michael Gambardella Maintained (AA) at Buy with Decreased Target to $26 on, Oct 10th, 2019

by: WOPRAI

Rajeev Lalwani Maintained (AAL) at Sell with Decreased Target to $24 on, Oct 10th, 2019

by: WOPRAI

Vivek Juneja Maintained (BAC) at Buy with Decreased Target to $30 on, Oct 10th, 2019

by: WOPRAI

Matthew Sharpe Maintained (BAH) at Buy with Increased Target to $78 on, Oct 10th, 2019

by: WOPRAI

Sidney Ho Maintained (AMAT) at Hold with Increased Target to $52 on, Oct 10th, 2019

by: WOPRAI

Rajeev Lalwani Maintained (ALGT) at Hold with Increased Target to $164 on, Oct 10th, 2019

by: WOPRAI

Rajeev Lalwani Maintained (ALK) at Buy with Increased Target to $76 on, Oct 10th, 2019

by: WOPRAI

John Nadel Maintained (AIZ) at Strong Buy with Increased Target to $154 on, Oct 10th, 2019

by: WOPRAI

Joshua Spector Initiated (CBT) at Hold and Held Target at $45 on, Oct 10th, 2019

by: WOPRAI

Matthew Sharpe Maintained (CACI) at Hold with Increased Target to $235 on, Oct 10th, 2019

David Lebovitz Initiated (ASND) at Buy and Held Target at $128 on, Oct 11th, 2019

David Lebovitz of Morgan Stanley, Initiated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $128 on, Oct 11th, 2019.

David has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David

  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $152 on, Thursday, August 29th, 2019